WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call

Oct 25, 2010, 11:45 ET from WuXi PharmaTech (Cayman) Inc.

SHANGHAI, Oct. 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 2010 on Tuesday, November 9, 2010, after the U.S. market closes.

(Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Wednesday, November 10, 2010, to discuss its third-quarter 2010 financial results and recent business activities. The conference call may be accessed by calling:

    United States:    1-866-519-4004
    China (Landline): 800-819-0121
    China (Mobile):   400-620-8038
    Hong Kong:        800-930-346
    United Kingdom:   0-808-234-6646
    International:    +65-6723-9381
    Conference ID:    20164344
    Web PIN:          8656

    A replay will be available two hours after the call's completion at:

    United States:  1-866-214-5335
    China North:    10-800-714-0386
    China South:    10-800-140-0386
    Hong Kong:      800-901-596
    United Kingdom: 0-800-731-7846
    International:  +61-2-8235-5000
    Conference ID:  20164344

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com

    For more information, please contact:

    Ronald Aldridge
    Director of Investor Relations
    Tel:   +1-201-585-2048
    Email: ir@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.